Mechanisms of clofibrate-induced apoptosis in Yoshida AH-130 hepatoma cells

Braissant, 1996, Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat, Endocrinology, 137, 354, 10.1210/endo.137.1.8536636 Bardot, 1995, The analysis of modified peroxisome proliferator responsive elements of the peroxisomal bifunctional enzyme in transfected HepG2 cells reveals two regulatory motifs, FEBS Lett, 360, 183, 10.1016/0014-5793(95)00097-S Park, 2004, Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer, Cancer Res, 64, 3701, 10.1158/0008-5472.CAN-03-3924 Lai, 2004, Rodent carcinogenicity of peroxisome proliferators and issues on human relevance, J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, 22, 37, 10.1081/GNC-120038005 Reddy, 1976, Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator, Cancer Res, 36, 1211 Ohmura, 1996, Hepatocyte proliferation induced by a single dose of a peroxisome proliferator, Am J Pathol, 148, 815 Lake, 2000, Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-beta1 gene expression in the rat, Syrian hamster and guinea pig, Mutat Res, 448, 213, 10.1016/S0027-5107(99)00238-9 Bentley, 1993, Hepatic peroxisome proliferation in rodents and its significance for humans, Food Chem Toxicol, 31, 857, 10.1016/0278-6915(93)90225-N Luci, 2007, Clofibrate treatment in pigs: effects on parameters critical with respect to peroxisome proliferator-induced hepatocarcinogenesis in rodents, BMC Pharmacol, 7, 6, 10.1186/1471-2210-7-6 Peters, 2005, Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?, J Mol Med, 83, 774, 10.1007/s00109-005-0678-9 Nishimura, 2007, Effect of fenofibrate on oxidative DNA damage and on gene expression related to cell proliferation and apoptosis in rats, Toxicol Sci, 97, 44, 10.1093/toxsci/kfm011 Peters, 1997, Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643, Carcinogenesis, 18, 2029, 10.1093/carcin/18.11.2029 Kliewer, 2001, Peroxisome proliferator-activated receptors: from genes to physiology, Recent Prog Horm Res, 56, 239, 10.1210/rp.56.1.239 Reddy, 1986, Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug, Environ Health Perspect, 65, 317 Cattley, 1994, Initiator-specific promotion of hepatocarcinogenesis by WY-14,643 and clofibrate, Carcinogenesis, 15, 1763, 10.1093/carcin/15.8.1763 Canuto, 1997, Rapid and extensive lethal action of clofibrate on hepatoma cells in vitro, Cell Death Differ, 4, 224, 10.1038/sj.cdd.4400224 Shabalina, 1999, Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells, Carcinogenesis, 20, 2237, 10.1093/carcin/20.12.2237 Simbula, 2004, The peroxisome proliferator BR931 kills FaO cells by p53-dependent apoptosis, Life Sci, 75, 271, 10.1016/j.lfs.2003.10.039 Xiao, 2006, Activation of peroxisome proliferator-activated receptor alpha enhances apoptosis in the mouse liver, Toxicol Sci, 92, 368, 10.1093/toxsci/kfl002 Elstner, 1998, Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice, Proc Natl Acad Sci USA, 95, 8806, 10.1073/pnas.95.15.8806 Tsubouchi, 2000, Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis, Biochem Biophys Res Commun, 270, 400, 10.1006/bbrc.2000.2436 Muzio, 2006, HMG-CoA reductase and PPARalpha are involved in clofibrate-induced apoptosis in human keratinocytes, Apoptosis, 11, 265, 10.1007/s10495-006-3559-y Tomiyama, 2007, Flow cytometric evaluation of synergistic pro-apoptotic effects of statins and clofibrates in IM-9 human lymphoblasts, Clin Exp Pharmacol Physiol, 34, 876, 10.1111/j.1440-1681.2007.04677.x Kim, 2006, Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells, Toxicol Appl Pharmacol, 215, 198, 10.1016/j.taap.2006.03.001 Ryu, 2007, Di(2-ethylhexyl) phthalate induces apoptosis through peroxisome proliferators-activated receptor-gamma and ERK 1/2 activation in testis of Sprague-Dawley rats, J Toxicol Environ Health A, 70, 1296, 10.1080/15287390701432160 Avis, 2005, Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition, Cancer Res, 65, 4181, 10.1158/0008-5472.CAN-04-3441 Canuto, 2003, Apoptosis induced by clofibrate in Yoshida AH-130 hepatoma cells: role of HMG-CoA reductase, J Lipid Res, 44, 56, 10.1194/jlr.M200072-JLR200 Barbiero, 1995, Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression, Exp Cell Res, 217, 410, 10.1006/excr.1995.1104 Cossarizza, 1993, A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1), Biochem Biophys Res Commun., 197, 40, 10.1006/bbrc.1993.2438 Szegezdi, 2006, Mediators of endoplasmic reticulum stress-induced apoptosis, EMBO Rep, 7, 880, 10.1038/sj.embor.7400779 Tan, 2006, Ubiquitous calpains promote caspase-12 and JNK activation during endoplasmic reticulum stress-induced apoptosis, J Biol Chem, 281, 16016, 10.1074/jbc.M601299200 Wang, 2000, Calpain and caspase: can you tell the difference?, Trends Neurosci, 23, 20, 10.1016/S0166-2236(99)01479-4 Chawla, 1994, Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival, Proc Natl Acad Sci USA, 91, 1786, 10.1073/pnas.91.5.1786 Harvengt, 1977, Plasma clofibric acid (CPIB) levels induced by three marketed compounds releasing clofibric acid, in volunteers, Int J Clin Pharmacol Biopharm, 15, 1 MICROMEDEX® Healthcare Series, POISINDEX® Managements, Clofibrate and related agents (www.thomsonhc.com). Canuto, 1998, Peroxisome proliferators induce apoptosis in hepatoma cells, Cancer Detect Prev, 22, 357, 10.1046/j.1525-1500.1998.CDOA44.x Matzno, 2006, Clofibrate-induced apoptosis is mediated by Ca2+-dependent caspase-12 activation, Life Sci, 78, 1892, 10.1016/j.lfs.2005.08.003 Nakamura, 2001, Characterization of clofibrate-induced retrograde Golgi membrane movement to the endoplasmic reticulum: clofibrate distinguishes the Golgi from the trans Golgi network, Biosci Biotechnol Biochem, 65, 1812, 10.1271/bbb.65.1812 Eizirik, 2008, The role for endoplasmic reticulum stress in diabetes mellitus, Endocr Rev, 29, 42, 10.1210/er.2007-0015 Nakagawa, 2000, Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta, Nature, 403, 98, 10.1038/47513 Urano, 2000, Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1, Science, 287, 664, 10.1126/science.287.5453.664 Oakes, 2006, The control of endoplasmic reticulum-initiated apoptosis by the BCL-2 family of proteins, Curr Mol Med, 6, 99, 10.2174/156652406775574587 Lam, 1994, Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes, Proc Natl Acad Sci USA, 91, 6569, 10.1073/pnas.91.14.6569 Jiang, 2005, Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition, J Biol Chem, 280, 14189, 10.1074/jbc.M413660200 Nixon, 2003, The calpains in aging and aging-related diseases, Ageing Res Rev, 2, 407, 10.1016/S1568-1637(03)00029-1 Nakagawa, 2000, Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis, J Cell Biol, 150, 887, 10.1083/jcb.150.4.887 Schotte, 1999, Non-specific effects of methyl ketone peptide inhibitors of caspases, FEBS Lett, 442, 117, 10.1016/S0014-5793(98)01640-8